Review of JP Morgan Conference

January 29 @ 11am – 2pm ET

Share:

RSVP to attend

Speakers

President & General Partner

Founding & Limited Partner

Chair Global Health & Purpose

Partner; National Co-Chair, M&A Team

Director of AI Technology

CEO & Founder

Co-founder & CEO

Founder & CEO

Supervisory Technology Analysis and Marketing Specialist

Founder & Author

Managing Partner

Co-Founder & CEO

Partners

Agenda

11:00 AM

Key Takeaways from JP Morgan 2025: Driving Global Health Through Purpose and Partnerships

Gil Bashe, Chair Global Health & Purpose, FINN Partners

11:15 AM

AI & Mental Health After JPM: What 2026 Demands Next

Mike Meaney, CEO, One Small Step

Meghna Mittel, Director of AI Technology at Elevance Health

11:30 AM

Modern Clinical Trials: What Works, What Breaks, What’s Next

Harsha K. Rajasimha, CEO and Founder, Jeeva Clinical Trials Inc

11:45 AM

The Future of Women’s Health Startups: Key Takeaways from JP Morgan 2026

Dr. Kate Stephenson, VP of Engineering, Cern Device

12:00 PM

Beyond SBIRs: NIH as a Technology Commercialization Partner

Michael Salgaller, Supervisory Technology Analysis and Marketing Specialist, The National Institutes of Health

12:10 PM

Introducing eo-vision AI: Building the Next Generation of AI-Driven Healthcare Solutions

Jonathan Brown, Co-Founder & CEO, eo-visionAI

12:20 PM

What ChatGPT Means for the Next Era of Healthcare

Chris Huber Reitz, Senior Director, Enterprise AI, Elevance Health

12:30 PM

From JPM to the Nursery: The Future of Women’s & Infant Health

Shaker Rawan, Founder & CEO, Woddle

12:45 PM

Changing the World Through Primary Care, Telehealth & AI: Lessons from JP Morgan 2026

Mathew Holt, Founder & Author, Health Care Blog

1:00 PM

Operationalizing AI: Lessons from the Front Lines

Meghna Mittel, Director of AI Technology at Elevance Health

Pervej Alam, Co Founder/ CEO, PulpDigital.ai

1:10 PM

Welcoming New Leadership: A Conversation with the Breakthrough Alliance Board

Bill Taranto, President, Merck GHI & Chair, Breakthrough Alliance Board

Peter Micca, Managing Partner, Caduceus Capital Partners

1:20 PM

Partnerships, Deals & Networks: What JP Morgan 2026 Signals for Healthcare

Mathew Kittay, Partner, Co‑Chair, Mergers & Acquisitions, Fox Rothschild LLP

1:30 PM

Investing in the AI Transformation of Healthcare: Lessons from JP Morgan 2026

Ainsley MacLean, General Partner, Ainsley & Born Capital

1:45 PM

From Innovation to Impact: Scaling Evidence-Based Health Technology After JP Morgan 2026

Richard Hanbury, CEO, Sana Health

Want to speak, sponsor, or participate more in our events?

Merck Global Health Innovation

Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.

FINN Partners

FINN Partners is more than an integrated marketing agency. We are smart, passionate communications advocates on a mission to make a difference in the world. We change the way brands relate to their markets. The way companies are positioned and perceived. The way causes become movements. How stakeholders view stakes. How great stories are told and shared to earn attention. Where leads are generated and results tracked. We’ve even changed the way people within an agency collaborate and pull together for the greater good. Our work reflects our values. What we do is how we do things. Whether inside our walls or on the front lines of business transformation and social change, we stand together to create meaningful and measurable impact on the world around us.

January 2026 Digital Health Symposium

Thursday January 29, 2026 @ 11am – 2pm EST

Add event to your calendar

Information Mediary Corp

IMC is the global leader in smart medication adherence solutions, having supplied over a million units to the clinical trials and research markets. IMC manufactures iOS and Android NFC-certified Med-ic Smart Blister Packages, eCAP Smart Medication Bottles and the temperature-aware Med-ic Smart Syringe Pack. IMC is active in the AI-enabled digital health field, offering its HIPAA compliant, secure CertiScan clinical research adherence cloud. IMC’s latest Lilipond AI project is aimed at detecting opiate abuse early to avoid dependence and addiction.